Vol. 12 No. 2 (2019)

REVIEWS

Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review)

Nikolai Nikolaevich Mamaev, T.L. Gindina, B.V. Afanas’ev

111-119
- PDF_2019-12-2-111-119 (Russian)
Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Zhernyakova

120-124
- PDF_2019-12-2-120-124 (Russian)
Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review)

O.N. Solopova, Vsevolod Andreevich Misyurin

125-144
- PDF_2019-12-2-125-144 (Russian)

LYMPHOID TUMORS

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev

145-153
- PDF_2019-12-2-145-153 (Russian)
Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

154-164
- PDF_2019-12-2-154-164 (Russian)
Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin

165-172
- PDF_2019-12-2-165-172 (Russian)
Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, N.A. Lyzhko, Yu.P. Finashutina, N.N. Kasatkina, D.S. Mar’in, E.S. Nesterova, N.N. Sharkunov, M.A. Baryshnikova, A.V. Misyurin

173-178
- PDF_2019-12-2-173-178 (Russian)
Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

Yuliya Eikhenovna Vinogradova, N.G. Chernova

179-184
- PDF_2019-12-2-179-184 (Russian)
A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis

Irina Aleksandrovna Shupletsova, A.M. Kovrigina, T.N. Moiseeva, E.I. Dorokhina, S.M. Kulikov

185-193
- PDF_2019-12-2-185-193 (Russian)

MYELOID TUMORS

Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

Oleg Aleksandrovich Shukhov, A.G. Turkina, E.Yu. Chelysheva, A.V. Bykova, A.N. Petrova, G.A. Gusarova, I.S. Nemchenko, A.O. Abdullaev, T.N. Obukhova, A.B. Sudarikov

194-201
- PDF_2019-12-2-194-201 (Russian)
Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

Ekaterina Yur’evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova, R.G. Shmakov

202-210
Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

Ekaterina Vadimovna Motyko, O.V. Blau, L.B. Polushkina, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, Yu.S. Ruzhenkova, E.V. Kleina, N.B. Pavlenko, A.M. Radzhabova, E.V. Karyagina, O.S. Uspenskaya, S.V. Voloshin, A.V. Chechetkin, I.S. Martynkevich

211-219
- PDF_2019-12-2-211-219 (Russian)

COMPLICATIONS OF CHEMOTHERAPY

Rhythm and Conduction Disorders in Patients Receiving Ibrutinib

E.I. Emelina, Gennadii Efimovich Gendlin, I.G. Nikitin, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin

220-230
- PDF_2019-12-2-220-230 (Russian)
Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

Anna Aleksandrovna Novikova, G.A. Klyasova, E.O. Gribanova, V.V. Ryzhko, T.A. Tupoleva, L.P. Mendeleeva, V.G. Savchenko

231-239
- PDF_2019-12-2-231-239 (Russian)

NEWS

Resolution of Expert Panel for the Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

240-242
- PDF_2019-12-2-240-242 (Russian)

REVIEWS

Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review)

Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review)

LYMPHOID TUMORS

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis

MYELOID TUMORS

Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

COMPLICATIONS OF CHEMOTHERAPY

Rhythm and Conduction Disorders in Patients Receiving Ibrutinib

Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

NEWS

Resolution of Expert Panel for the Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

Update site

oa-antiplagiat

Make a Submission

Indexing Databases

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

Information

Keywords